Structural Formula (Mil05 0001 01)
Milrinone Lactate In Dextrose Injection, Solution
Product Images NDC 25021-313
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate In Dextrose (NDC 25021-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Bag Label (Mil05 0001 02)
Milrinone Lactate in 5% Dextrose Injection is a single-dose sterile solution for intravenous use. The container and closure are PVC-free and DEHP-free, and do not contain natural rubber latex. Each milliliter of the solution contains 0.2 mg of milrinone lactate, 0.282 mg of lactic acid, and 54.3 mg of dextrose hydrous USP in water for injection USP. The usual dosage should be administered intravenously as directed by a physician. The storage should be at a temperature of 20°C to 25°C (68°F to 77°F) and should not be frozen. It should not be used in series connections and should not be administered simultaneously with blood. This drug is manufactured in India by SAGENT Pharmaceuticals, and further details can be obtained from the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
